4.7 Article

Mast cells regulate CD4(+) T-cell differentiation in the absence of antigen presentation

期刊

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 142, 期 6, 页码 1894-+

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2018.01.038

关键词

Nicotinamide adenine dinucleotide; mast cells; T cells; antigen presentation; MHC; T-cell receptor; CD4(+) T-cell differentiation; dendritic cells; macrophages; Listeria monocytogenes; cytokine

资金

  1. National Institutes of Health [R01NS073635, R01MH110438, R01 HL096795, U01 HL126497, R01AG039449]
  2. Swiss Society of Cardiac Surgery
  3. FIS-ISCIII [PI10/02 511]
  4. Fundacion Ramon Areces [CIVP16A1843]
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL126497] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110438] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON AGING [R01AG039449] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: Given their unique capacity for antigen uptake, processing, and presentation, antigen-presenting cells (APCs) are critical for initiating and regulating innate and adaptive immune responses. We have previously shown the role of nicotinamide adenine dinucleotide (NAD(+)) in T-cell differentiation independently of the cytokine milieu, whereas the precise mechanisms remained unknown. Objective: The objective of this study is to further dissect the mechanism of actions of NAD(+) and determine the effect of APCs on NAD(+)-mediated T-cell activation. Methods: Isolated dendritic cells and bone marrow-derived mast cells (MCs) were used to characterize the mechanisms of action of NAD(+) on CD4(+) T-cell fate in vitro. Furthermore, NAD(+)-mediated CD4(+) T-cell differentiation was investigated in vivo by using wild-type C57BL/6, MC-/-, MHC class II-/-, Wiskott-Aldrich syndrome protein (WASP)(-/-), 5C.C7 recombination-activating gene 2 (Rag2)(-/-), and CD11b-DTR transgenic mice. Finally, we tested the physiologic effect of NAD(+) on the systemic immune response in the context of Listeria monocytogenes infection. Results: Our in vivo and in vitro findings indicate that after NAD(+) administration, MCs exclusively promote CD4(+) T-cell differentiation, both in the absence of antigen and independently of major APCs. Moreover, we found that MCs mediated CD4(+) T-cell differentiation independently of MHC II and T-cell receptor signaling machinery. More importantly, although treatment with NAD(+) resulted in decreased MHC II expression on CD11c(+) cells, MC-mediated CD4(+) T-cell differentiation rendered mice resistant to administration of lethal doses of L monocytogenes. Conclusions: Collectively, our study unravels a novel cellular and molecular pathway that regulates innate and adaptive immunity through MCs exclusively and underscores the therapeutic potential of NAD(+) in the context of primary immunodeficiencies and antimicrobial resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据